| Bioactivity | Byakangelicol, isolated from Angelica dahurica, inhibits interleukin-1beta (IL-1beta) -induced prostaglandin E2 (PGE2) release in A549 cells mediated by suppression of cyclooxygenase-2 (COX-2) expression and the activity of COX-2 enzyme. Byakangelicol has therapeutic potential as an anti-inflammatory drug on airway inflammation[1]. |
| Name | Byakangelicol |
| CAS | 26091-79-2 |
| Formula | C17H16O6 |
| Molar Mass | 316.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Byakangelicol
CAS: 26091-79-2 F: C17H16O6 W: 316.31
Byakangelicol, isolated from Angelica dahurica, inhibits interleukin-1beta (IL-1beta) -induced prostaglandin E2 (PGE2) r
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.